MedCity News March 20, 2022
While the pandemic has disrupted demand for certain healthcare sectors, it has accelerated innovation and provided an opportunity for investment in other areas. In particular, there’s been rapid growth in virtual and home-based care delivery, along with the adoption of technology platforms.
Faced with intense competition and rising valuation multiples to acquire high-quality healthcare platforms, healthcare private equity firms need to enhance their diligence efforts and expand their value creation playbooks to mitigate risk and continue to yield outsized returns relative to other sectors and public markets.
During the pandemic, there’s been a convergence of several secular and short-term trends that have fueled steady growth in healthcare PE. The tremendous amount of dry powder awaiting deployment and the cheap...
Today's Sponsors
Today's Sponsor